Maulik Nanavaty - 21 Feb 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: SVP & Pres, Neuromodulation
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 21 Feb 2022
Transactions value $: -$25,232
Form type: 4
Date filed: 23 Feb 2022, 15:18
Previous filing: 22 Feb 2022
Next filing: 24 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+1.71K	+0.98%	$0.00	177K	21 Feb 2022	Direct	F1
transaction	BSX	Common Stock	Tax liability	-$25.2K	-593	-0.34%	$42.55	176K	21 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-1.71K	-50%	$0.00	1.71K	21 Feb 2022	Common Stock	1.71K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.